RMDN3 and carcinoma: Ongoing studies of our group examined the interaction of PTPIP51 and PTP1B in breast carcinomas of no special type and showed a significant enhancement of the interaction in grade 3 carcinomas compared to grade 1 and 2 carcinomas.